Last night, the FDA issued an emergency use authorization (EUA) for convalescent plasma to treat COVID-19, even though there are no randomized clinical trials demonstrating efficacy and safety. Does this plasma work? Who knows? But that didn't stop the FDA from issuing the EUA, almost certainly as a result of intense political pressure from the Trump Administration.
David Gorski / August 24, 2020